• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    34.57 Up 0.23(0.67%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:34.34
    Open:34.54
    Bid:31.62 x 100
    Ask:35.50 x 100
    1y Target Est:35.67
    Beta:-0.16
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:33.84 - 34.67
    52wk Range:31.34 - 40.50
    Volume:598,592
    Avg Vol (3m):772,917
    Market Cap:2.40B
    P/E (ttm):27.59
    EPS (ttm):1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MYGNUp 0.67%2.40B
    ABTDown 0.22%73.56B

    Key Statistics

    Forward P/E (1 yr):19.53
    P/S (ttm):3.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :1.45
    Quarterly EPS Est (Jun-15) :0.41
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):1.74

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback